{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Harmine", "TAZ", "breast cancer cell", "epithelial-mesenchymal transition", "metastasis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35812064", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "15"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "2156-6976", "JournalIssue": {"Volume": "12", "Issue": "6", "PubDate": {"Year": "2022"}}, "Title": "American journal of cancer research", "ISOAbbreviation": "Am J Cancer Res"}, "ArticleTitle": "Harmine suppresses breast cancer cell migration and invasion by regulating TAZ-mediated epithelial-mesenchymal transition.", "Pagination": {"StartPage": "2612", "EndPage": "2626", "MedlinePgn": "2612-2626"}, "Abstract": {"AbstractText": ["Breast cancer is a highly lethal disease due to cancer metastasis. Harmine (HM), a \u03b2-carboline alkaloid, is present in various medicinal plants. Our previous study demonstrated that HM suppresses cell proliferation and migration by regulating TAZ in breast cancer cells and accelerates apoptosis. Epithelial-mesenchymal transition (EMT) plays an important role in the development of breast cancer by inducing the characteristics of cancer stem cells, cancer metastasis and recurrence. Overexpression of TAZ was shown to mediate EMT in breast cancer cells. We aimed to investigate whether HM inhibits EMT and metastasis of breast cancer cells by targeting TAZ. In this study, the cells treated with HM or with downregulated expression of TAZ showed an increase in epithelial markers and decrease in mesenchymal markers in breast cancer cells. Consistently, the breast cancer cells treated with HM or with downregulated expression of TAZ showed suppressed migration and proliferation. Moreover, TAZ overexpression reversed EMT and metastasis induced by HM in breast cancer cells. Thus, HM suppresses EMT and metastasis and invasion by targeting TAZ in breast cancer cells. HM can be used as an anticancer drug for breast cancer treatment and chemoprevention."], "CopyrightInformation": "AJCR Copyright \u00a9 2022."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China."}, {"Identifier": [], "Affiliation": "Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China."}], "LastName": "He", "ForeName": "Jinrong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China."}, {"Identifier": [], "Affiliation": "Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China."}], "LastName": "Chen", "ForeName": "Shanshan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Chinese Medicine, Humanwell Healthcare (Group) Co., Ltd. Wuhan 430075, Hubei, China."}], "LastName": "Yu", "ForeName": "Tong", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China."}, {"Identifier": [], "Affiliation": "Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China."}], "LastName": "Chen", "ForeName": "Weiqun", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China."}, {"Identifier": [], "Affiliation": "Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China."}], "LastName": "Huang", "ForeName": "Jin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China."}, {"Identifier": [], "Affiliation": "Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China."}], "LastName": "Peng", "ForeName": "Caixia", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China."}, {"Identifier": [], "Affiliation": "Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China."}], "LastName": "Ding", "ForeName": "Yu", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Cancer Res", "NlmUniqueID": "101549944", "ISSNLinking": "2156-6976"}, "CoiStatement": "None."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.", "ArticleIdList": ["30207593"]}, {"Citation": "Benson JR, Jatoi I. The global breast cancer burden. Future Oncol. 2012;8:697\u2013702.", "ArticleIdList": ["22764767"]}, {"Citation": "Tomaskovic-Crook E, Thompson EW, Thiery JP. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 2009;11:213.", "ArticleIdList": ["PMC2815537", "19909494"]}, {"Citation": "Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016;35:645\u2013654.", "ArticleIdList": ["27878502"]}, {"Citation": "Liu X, Yun F, Shi L, Li ZH, Luo NR, Jia YF. Roles of signaling pathways in the epithelial-mesenchymal transition in cancer. Asian Pac J Cancer Prev. 2015;16:6201\u20136206.", "ArticleIdList": ["26434817"]}, {"Citation": "Li Z, Wang Y, Zhu Y, Yuan C, Wang D, Zhang W, Qi B, Qiu J, Song X, Ye J, Wu H, Jiang H, Liu L, Zhang Y, Song LN, Yang J, Cheng J. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Mol Oncol. 2015;9:1091\u20131105.", "ArticleIdList": ["PMC5528756", "25704916"]}, {"Citation": "Ye X, Brabletz T, Kang Y, Longmore GD, Nieto MA, Stanger BZ, Yang J, Weinberg RA. Upholding a role for EMT in breast cancer metastasis. Nature. 2017;547:E1\u2013E3.", "ArticleIdList": ["PMC6283276", "28682326"]}, {"Citation": "Ge L, Li DS, Chen F, Feng JD, Li B, Wang TJ. TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells. Int J Oncol. 2017;51:307\u2013315.", "ArticleIdList": ["28534974"]}, {"Citation": "Xiao H, Jiang N, Zhou B, Liu Q, Du C. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Cancer Sci. 2015;106:151\u2013159.", "ArticleIdList": ["PMC4399022", "25495189"]}, {"Citation": "Patel K, Gadewar M, Tripathi R, Prasad SK, Patel DK. A review on medicinal importance, pharmacological activity and bioanalytical aspects of beta-carboline alkaloid \u201cHarmine\u201d. Asian Pac J Trop Biomed. 2012;2:660\u2013664.", "ArticleIdList": ["PMC3609365", "23569990"]}, {"Citation": "Ding Y, He J, Huang J, Yu T, Shi X, Zhang T, Yan G, Chen S, Peng C. Harmine induces anticancer activity in breast cancer cells via targeting TAZ. Int J Oncol. 2019;54:1995\u20132004.", "ArticleIdList": ["PMC6521938", "31081045"]}, {"Citation": "Geng X, Ren Y, Wang F, Tian D, Yao X, Zhang Y, Tang J. Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy. Biochem Biophys Res Commun. 2018;498:99\u2013104.", "ArticleIdList": ["PMC5857254", "29501493"]}, {"Citation": "Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A, Wen W, Zhu Q. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One. 2013;8:e65539.", "ArticleIdList": ["PMC3677905", "23762387"]}, {"Citation": "Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, Turski A, Azodi Y, Yang Y, Doucette T, Colman H, Sulman EP, Lang FF, Rao G, Copray S, Vaillant BD, Aldape KD. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011;25:2594\u20132609.", "ArticleIdList": ["PMC3248681", "22190458"]}, {"Citation": "Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, Daidone MG, Dupont S, Basso G, Bicciato S, Piccolo S. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759\u2013772.", "ArticleIdList": ["22078877"]}, {"Citation": "Liu J, Ye L, Li Q, Wu X, Wang B, Ouyang Y, Yuan Z, Li J, Lin C. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity. J Pathol. 2018;244:71\u201383.", "ArticleIdList": ["28991374"]}, {"Citation": "Matteucci E, Maroni P, Luzzati A, Perrucchini G, Bendinelli P, Desiderio MA. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors. Eur J Cancer. 2013;49:231\u2013244.", "ArticleIdList": ["22717556"]}, {"Citation": "Pattabiraman DR, Weinberg RA. Targeting the epithelial-to-mesenchymal transition: the case for differentiation-based therapy. Cold Spring Harb Symp Quant Biol. 2016;81:11\u201319.", "ArticleIdList": ["PMC5722631", "28057845"]}, {"Citation": "Ribatti D. Epithelial-mesenchymal transition in morphogenesis, cancer progression and angiogenesis. Exp Cell Res. 2017;353:1\u20135.", "ArticleIdList": ["28257786"]}, {"Citation": "Li C, Wang Y, Wang C, Yi X, Li M, He X. Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells. Phytomedicine. 2017;28:10\u201318.", "ArticleIdList": ["28478808"]}, {"Citation": "Uhl KL, Schultz CR, Geerts D, Bachmann AS. Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma. Cancer Cell Int. 2018;18:82.", "ArticleIdList": ["PMC5992763", "29977157"]}, {"Citation": "Wu LW, Zhang JK, Rao M, Zhang ZY, Zhu HJ, Zhang C. Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment. Onco Targets Ther. 2019;12:4585\u20134593.", "ArticleIdList": ["PMC6580126", "31354292"]}, {"Citation": "Ruan S, Jia F. Potential antitumor effect of harmine in the treatment of thyroid cancer. Evid Based Complement Alternat Med. 2017;2017:9402615.", "ArticleIdList": ["PMC5320370", "28270853"]}, {"Citation": "Li Z, Chen L, He C, Han Y, Han M, Zhang Y, Qi L, Xing X, Huang W, Gao Z, Xing J. Improving anti-tumor outcomes for colorectal cancer therapy through in situ thermosensitive gel loading harmine. Am J Transl Res. 2020;12:1658\u20131671.", "ArticleIdList": ["PMC7270021", "32509167"]}, {"Citation": "Du B, Shim JS. Targeting Epithelial-Mesenchymal Transition (EMT) to overcome drug resistance in cancer. Molecules. 2016;21:965.", "ArticleIdList": ["PMC6273543", "27455225"]}, {"Citation": "Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem. 2007;282:22089\u201322101.", "ArticleIdList": ["17513865"]}, {"Citation": "Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller N, Sch\u00fcbeler D, van Nimwegen E, Christofori G. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23:768\u2013783.", "ArticleIdList": ["23764001"]}, {"Citation": "Rokavec M, \u00d6ner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, Slotta-Huspenina J, Bader FG, Greten FR, Hermeking H. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest. 2014;124:1853\u20131867.", "ArticleIdList": ["PMC3973098", "24642471"]}, {"Citation": "Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem. 2005;280:11740\u201311748.", "ArticleIdList": ["15647282"]}, {"Citation": "Dobrokhotov O, Samsonov M, Sokabe M, Hirata H. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms. Clin Transl Med. 2018;7:23.", "ArticleIdList": ["PMC6087706", "30101371"]}, {"Citation": "He J, Bao Q, Yan M, Liang J, Zhu Y, Wang C, Ai D. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease. Br J Pharmacol. 2018;175:1354\u20131361.", "ArticleIdList": ["PMC5866970", "28369744"]}, {"Citation": "Yuan L, Zhou M. Jiedu sangen decoction inhibits the invasion and metastasis of colorectal cancer cells by regulating EMT through the hippo signaling pathway. Evid Based Complement Alternat Med. 2019;2019:1431726.", "ArticleIdList": ["PMC6614995", "31341488"]}, {"Citation": "Jiang Z, Zhou C, Cheng L, Yan B, Chen K, Chen X, Zong L, Lei J, Duan W, Xu Q, Li X, Wang Z, Ma Q, Ma J. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. J Exp Clin Cancer Res. 2018;37:69.", "ArticleIdList": ["PMC5870346", "29587800"]}, {"Citation": "Yu S, Jing L, Yin XR, Wang MC, Chen YM, Guo Y, Nan KJ, Han LL. MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP. Oncotarget. 2017;8:99757\u201399771.", "ArticleIdList": ["PMC5725129", "29245938"]}, {"Citation": "Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med. 2018;12:361\u2013373.", "ArticleIdList": ["PMC6186394", "30043221"]}, {"Citation": "Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell. 2012;22:725\u2013736.", "ArticleIdList": ["PMC3522773", "23201165"]}, {"Citation": "Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D, Reichardt W, Bronsert P, Brunton VG, Pilarsky C, Winkler TH, Brabletz S, Stemmler MP, Brabletz T. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol. 2017;19:518\u2013529.", "ArticleIdList": ["28414315"]}, {"Citation": "Shen S, Huang K, Wu Y, Ma Y, Wang J, Qin F, Ma J. A miR-135b-TAZ positive feedback loop promotes epithelial-mesenchymal transition (EMT) and tumorigenesis in osteosarcoma. Cancer Lett. 2017;407:32\u201344.", "ArticleIdList": ["28823959"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "18"}, {"Year": "2022", "Month": "5", "Day": "27"}, {"Year": "2022", "Month": "7", "Day": "11", "Hour": "3", "Minute": "41"}, {"Year": "2022", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35812064", "PMC9251681"]}}], "PubmedBookArticle": []}